Test my supply
+2 more ↓
61%
Finnrick rating
#258 of 301 ranked vendors
79 of 132 classifiable tests passed
methodology · Purity focus
Finnrick analysis

Peptide Sciences' purity-focused record is strongest in GHK-Cu, PT-141, Semaglutide, and Ipamorelin, where identity and purity evidence is comparatively cleaner but sometimes dated or no-batch. Retatrutide, CJC-1295, Tesamorelin, and Tirzepatide drive dispersion with identity failures, purity misses, and large fill swings, including recent volatility.

methodology →
vendor intelligence report
Vendor Intelligence Report: Peptide Sciences

The dossier follows a post-shutdown P-Sciences lookalike through WHOIS, a Fort Lauderdale mail-drop, Florida registry searches and crypto payment rails. It also separates stale coupon funnels, QR Peptides and peptides.gg from the original brand.

27 pages4 risk factors assessed3 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$1.30
91%
6
2
Semaglutide
$28.33
81%
15
3
Ipamorelin
$8.80
78%
9
4
PT-141
$5.50
78%
6
5
Tirzepatide
$6.67
68%
17
6
BPC-157
$9.50
60%
13
7
Retatrutide
$17.92
56%
41
8
Melanotan II
$4.67
55%
10
9
Tesamorelin
$10.42
38%
4
10
CJC-1295
$11.20
17%
11
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%21 May 2025: 60%11 Jun 2025: 60%27 Jun 2025: 60%30 Jun 2025: 60%30 Jun 2025: 61%3 Jul 2025: 61%3 Jul 2025: 61%17 Jul 2025: 61%17 Jul 2025: 61%22 Jul 2025: 61%23 Jul 2025: 62%25 Jul 2025: 62%31 Jul 2025: 62%4 Aug 2025: 62%4 Aug 2025: 61%12 Aug 2025: 62%3 Oct 2025: 62%9 Oct 2025: 58%4 Nov 2025: 58%4 Feb 2026: 58%10 Feb 2026: 58%11 Feb 2026: 59%13 Feb 2026: 59%15 Feb 2026: 60%15 Feb 2026: 61%20 Feb 2026: 61%20 Feb 2026: 61%26 Feb 2026: 61%1 Mar 2026: 61%1 Mar 2026: 61%2 Mar 2026: 61%3 Mar 2026: 61%2 Apr 2026: 60%28 Apr 2026: 61%28 Apr 2026: 61%28 Apr 2026: 60%6 May 2026: 60%17 Jun 2026: 61%1 Jul 2026: 61%20 Jul 2026: 61%10 Aug 2026: current 61%60%58%61%May 25Aug 26
Test my supply
Peptide Sciences test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
20 Jul 2026Fail
Tesamorelin
lab nameView COA
1 Jul 2026Pass
Tirzepatide
lab nameView COA
17 Jun 2026Pass
Retatrutide
lab nameView COA
6 May 2026Fail
CJC-1295 (No DAC)
lab nameView COA
28 Apr 2026Fail
Retatrutide
lab nameView COA
28 Apr 2026Fail
Tesamorelin
lab nameView COA
28 Apr 2026Fail
Retatrutide
lab nameView COA
2 Apr 2026Fail
Retatrutide
lab nameView COA
3 Mar 2026Fail
Tirzepatide
lab nameView COA
2 Mar 2026Pass
Retatrutide
lab nameView COA
1-10 of 132

About Peptide Sciences test results from Finnrick

Peptide Sciences is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 10 peptides and 132 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Peptide Sciences peptides in this dataset are Semaglutide (15 tests), Retatrutide (41 tests) and Melanotan II (10 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 132 recent tests.

Corrections
No corrections.
Test my supply